Hung Sing Li
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Research and Treatments
Papers in
- Oncology 4
- Cancer Treatment and Pharmacology 1
- Co-authors
- Ariel Ka-Man Chow (6 shared papers)Lui Ng (6 shared papers)Thomas Yau (6 shared papers)Kenrie P. Y. Hui (3 shared papers)Michael C. W. Chan (3 shared papers)Malik Peiris (3 shared papers)John M. Nicholls (2 shared papers)Man Chun Cheung (2 shared papers)
In The Last Decade
Hung Sing Li
13 papers receiving 292 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 55
- Biotechnology 29
- Oncology 88
- Infectious Diseases 57
- Immunology 53
Countries citing papers authored by Hung Sing Li
This map shows the geographic impact of Hung Sing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung Sing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung Sing Li more than expected).
Fields of papers citing papers by Hung Sing Li
This network shows the impact of papers produced by Hung Sing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung Sing Li. The network helps show where Hung Sing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung Sing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 64 | |
| 2 | 2018 | 40 | |
| 3 | 2016 | 32 | |
| 4 | 2015 | 31 | |
| 5 | 2012 | 28 | |
| 6 | 2021 | 26 | |
| 7 | 2014 | 21 | |
| 8 | 2013 | 16 | |
| 9 | 2015 | 12 | |
| 10 | 2012 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2015 | 7 | |
| 13 | 2023 | 1 |
About Hung Sing Li
Hung Sing Li is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Immunology and Cancer Research, having authored 13 papers that have together received 293 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Influenza Virus Research Studies (2 papers), COVID-19 Clinical Research Studies (2 papers), interferon and immune responses (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Neuroblastoma Research and Treatments (1 paper), Cancer Treatment and Pharmacology (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Cancer Research (55 citations), Biotechnology (29 citations), Oncology (88 citations), Infectious Diseases (57 citations) and Immunology (53 citations). Hung Sing Li has collaborated with scholars based in Hong Kong and China. Frequent co-authors include Ariel Ka-Man Chow, Lui Ng, Thomas Yau, Kenrie P. Y. Hui, Michael C. W. Chan, Malik Peiris, John M. Nicholls, Man Chun Cheung, Alvin H.K. Cheung and Oswens Siu‐Hung Lo. Their work appears in journals such as Current Cancer Drug Targets, Antiviral Research, PLoS ONE, Scientific Reports and Frontiers in Molecular Biosciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.